DLG4 and Alzheimer disease: Mechanistically, SI resulted in decreased OXT levels and upregulated OXT receptor expression while also exacerbating AD‐related pathological features, including increased Aβ plaque deposition, aberrant microglial proliferation, and reduced PSD‐95 expression in the prefrontal cortex.